Involvement of lncRNA-mediated signaling pathway in the development of cervical cancer.

Involvement of lncRNA-mediated signaling pathway in the development of cervical cancer. Eur Rev Med Pharmacol Sci. 2019 May;23(9):3672-3687 Authors: Sun W, Shen NM, Fu SL Abstract Cervical cancer (CC) develops, after human papillomavirus (HPV), an infection transmitted through sexual contact. Worldwide estimates are around>500,000 CC diagnoses and>300,000 related deaths annually, and CC remains the second most devastating type of cancers in women after breast cancer. Although the vaccine against HPV has reduced the incidence of infection and the treatment efficacy of the early-stage diagnoses has improved, many challenges remain in terms of treatment efficacy, during the late-stage and prevention of chemotherapy resistance development. Thus, new tools for prompt diagnoses and more effective curative treatments (including the development of targeted gene therapies) are needed. The long non-coding RNAs (LncRNAs) (>200 nucleotides) are transcripts that do not encode for any proteins, and they have been linked to the development of cancers (such as leukemia and breast, colorectal, and liver cancers). Some lncRNAs have been identified as the cause of the dysregulation of the oncogenes and progression of CC, but these studies are still very preliminary. In this review, we explore the literature for lncRNAs involved in the development of CC and their signaling pathways to identify those that might serve as early diagnostic biomarkers, or as targets for ...
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research

Related Links:

Pfizer has agreed to buy Array Biopharma in a $10.64 billion cash deal.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
Children with asthma and recurrent wheezing can safely receive the nasal spray influenza vaccine, a large study found.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Source: BMJ News - Category: General Medicine Source Type: research
CCR Grand Rounds Kimberly Stegmaier, M.D., Professor of Pediatrics at Harvard Medical School and the Ted Williams Chair at Dana-Farber Cancer Institute, has advanced the application of genomics to drug and protein target discovery for pediatric cancers. She is the Vice Chair for Pediatric Oncology Research, co-director of the Pediatric Hematologic Malignancy Program and an attending physician providing clinical care in Pediatric Oncology at the Dana-Farber Cancer Institute and Boston Children ’ s Hospital. Dr. Stegmaier is also an Institute Member of the Broad Institute of Harvard and MIT. She has served as a Council...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
Abstract We hypothesize that, ancestrally, sex-specific immune modulation evolved to facilitate survival of the pregnant person in the presence of an invasive placenta and an immunologically challenging pregnancy - an idea we term the 'pregnancy compensation hypothesis' (PCH). Further, we propose that sex differences in immune function are mediated, at least in part, by the evolution of gene content and dosage on the sex chromosomes, and are regulated by reproductive hormones. Finally, we propose that changes in reproductive ecology in industrialized environments exacerbate these evolved sex differences, resulting...
Source: Trends in Genetics : TIG - Category: Genetics & Stem Cells Authors: Tags: Trends Genet Source Type: research
During this first awards program the Office of Equity, Diversity and Inclusion (EDI) will honor these NIH employees and fellows who are community members and allies nominated for their exemplary work helping to create safer spaces for SGM at the NIH. These awardees lead by example and encourage others to demonstrate unconditional compassion, leadership, and understanding towards members of the SGM community: Dr. Vivian Ota Wang, National Cancer Institute; Dr. Christopher Wheldon, National Cancer Institute; Adam Cornish, National Institute on Aging; Dr. Karen Parker, Sexual&Gender Minority Research Office, Tricia Coffey...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
VBI Vaccines Inc said on Monday a late-stage study was unsuccessful in showing two doses of its hepatitis B vaccine were as effective as three doses of an older vaccine from GlaxoSmithKline, sending its shares plunging 66%.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Findings seen among pre - /perimenopausal survivors of stage 0 to III breast cancer
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Endocrinology, Family Medicine, Geriatrics, Gynecology, Internal Medicine, Nursing, Oncology, Orthopedics, Rheumatology, Journal, Source Type: news
According to data from the World Health Organization, 41,000 measles cases were reported from January to June 2018 across 53 European countries
Source: Health News: CBSNews.com - Category: Consumer Health News Source Type: news
For several decades, certain cancer centers have been allowed by the U.S. government to charge more for the care they give. A new study finds the care given at these centers isn't very different from that received at other top-notch facilities.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | Chemotherapy | Colorectal Cancer | Drugs & Pharmacology | Gene Therapy | Genetics | Genital Warts | Human Papillomavirus (HPV) | Leukemia | Liver | Study | Urology & Nephrology | Vaccines | Women